739 related articles for article (PubMed ID: 17419972)
1. Mucus structure and properties in cystic fibrosis.
Rubin BK
Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972
[TBL] [Abstract][Full Text] [Related]
2. Physiology of airway mucus clearance.
Rubin BK
Respir Care; 2002 Jul; 47(7):761-8. PubMed ID: 12088546
[TBL] [Abstract][Full Text] [Related]
3. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
[TBL] [Abstract][Full Text] [Related]
4. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
Henke MO; John G; Germann M; Lindemann H; Rubin BK
Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563
[TBL] [Abstract][Full Text] [Related]
5. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
6. Mucolytics, expectorants, and mucokinetic medications.
Rubin BK
Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730
[TBL] [Abstract][Full Text] [Related]
7. CPAP has no effect on clearance, sputum properties, or expectorated volume in cystic fibrosis.
Aquino ES; Shimura F; Santos AS; Goto DM; Coelho CC; de Fuccio MB; Saldiva PH; Lorenzi-Filho G; Rubin BK; Nakagawa NK
Respir Care; 2012 Nov; 57(11):1914-9. PubMed ID: 22417659
[TBL] [Abstract][Full Text] [Related]
8. Effect of osmolality on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
Shibuya Y; Wills PJ; Cole PJ
Respirology; 2003 Jun; 8(2):181-5. PubMed ID: 12753533
[TBL] [Abstract][Full Text] [Related]
9. Is cystic fibrosis mucus abnormal?
King M
Pediatr Res; 1981 Feb; 15(2):120-2. PubMed ID: 7254936
[TBL] [Abstract][Full Text] [Related]
10. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients.
Deneuville E; Perrot-Minot C; Pennaforte F; Roussey M; Zahm JM; Clavel C; Puchelle E; de Bentzmann S
Am J Respir Crit Care Med; 1997 Jul; 156(1):166-72. PubMed ID: 9230742
[TBL] [Abstract][Full Text] [Related]
11. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
Feng W; Garrett H; Speert DP; King M
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
[TBL] [Abstract][Full Text] [Related]
12. Mechanical airway clearance using the frequencer electro-acoustical transducer in cystic fibrosis.
Cantin AM; Bacon M; Berthiaume Y
Clin Invest Med; 2006 Jun; 29(3):159-65. PubMed ID: 17058435
[TBL] [Abstract][Full Text] [Related]
13. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage.
App EM; Kieselmann R; Reinhardt D; Lindemann H; Dasgupta B; King M; Brand P
Chest; 1998 Jul; 114(1):171-7. PubMed ID: 9674466
[TBL] [Abstract][Full Text] [Related]
14. The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4.
Kater A; Henke MO; Rubin BK
Ann N Y Acad Sci; 2007 Sep; 1112():140-53. PubMed ID: 17496063
[TBL] [Abstract][Full Text] [Related]
15. The physiology of mucus and sputum production in the respiratory system.
Richardson M
Nurs Times; 2003 Jun 10-16; 99(23):63-4. PubMed ID: 12838653
[TBL] [Abstract][Full Text] [Related]
16. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
Puchelle E; de Bentzmann S; Zahm JM
Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
[TBL] [Abstract][Full Text] [Related]
17. Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions.
Davies JR; Svitacheva N; Lannefors L; Kornfält R; Carlstedt I
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):321-30. PubMed ID: 10567212
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory reaction and airway damage in cystic fibrosis.
Barton AD; Ryder K; Lourenço RV; Dralle W; Weiss SG
J Lab Clin Med; 1976 Sep; 88(3):423-6. PubMed ID: 8575
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity and mucus structure and function.
Sheehan JK; Kesimer M; Pickles R
Novartis Found Symp; 2006; 279():155-66; discussion 167-9, 216-9. PubMed ID: 17278393
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis: a disease of vulnerability to airway surface dehydration.
Boucher RC
Trends Mol Med; 2007 Jun; 13(6):231-40. PubMed ID: 17524805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
